A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis. (2015)

First Author: Boeree MJ
Attributed to:  Tuberculosis Treatment Trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1164/rccm.201407-1264oc

PubMed Identifier: 25654354

Publication URI: http://europepmc.org/abstract/MED/25654354

Type: Journal Article/Review

Volume: 191

Parent Publication: American journal of respiratory and critical care medicine

Issue: 9

ISSN: 1073-449X